Hints and tips:
Related Special Reports
...Alongside Ubben, Bayer nominated Nancy Simonian, the former CEO of US biotech company Syros Pharmaceuticals, and Lori Schechter, the former general counsel of US healthcare group McKesson, to join its supervisory...
...Metagenomi, a pre-clinical group backed by Moderna and Bayer, priced its $94mn IPO last week at the bottom of its target range, and fell 31 per cent on its first day of trading on Friday....
...In an interview days before her two-year anniversary as CEO, Sistani described the challenge she faces as less financial than strategic: to pull off a business pivot as profound as those that have convulsed...
...Days after he joined, Anderson said he would consider all options....
...“Those days are ending,” he said....
...Delays in diagnosis of Covid had also complicated the rollout, because the drug should be taken within five days of infection, they said....
...Shares of Kenvue, the consumer arm of healthcare giant Johnson & Johnson, jumped on their first day of trading after an upsized initial public offering that marked the biggest US listing in almost 18 months...
...The FT’s US pharmaceutical correspondent Jamie Smyth helps us explore whether J&J’s use of this manoeuvre is setting a precedent for corporations to evade accountability in America....
...AbbVie and Eli Lilly have withdrawn from the deal after the German conglomerate Bayer’s pharmaceutical chief executive told the Financial Times on Monday that it was reducing its UK footprint and cutting...
...These days, consumer-facing healthcare companies — a slow-growth, low-margin yet steady business — tend to fetch higher valuations....
...of pharmaceuticals for the Americas....
...Janssen is the pharmaceutical division of J&J....
...Eli Lilly, Amgen, Pfizer and Regeneron are among the companies aiming to compete with market leader Novo Nordisk in a category which analysts say is rapidly becoming a healthcare priority and could produce...
...The very real cost is lives lost with every day of delay.”...
...“By the time I realised my mother had Covid, it had been two days since she had eaten or drunk anything,” she said....
...Bayer shuns ‘innovation unfriendly’ Europe The German pharmaceutical company has said it is shifting the focus of its drugs business to the US and away from Europe, where governments are making “big mistakes...
...Hillhouse InvestmentO: 7; L: 7; I: 7; Total: 21The private equity firm’s legal team worked with software developers to create an online portal combining several applications to help on day-to-day work, such...
...Gabriel Harnier group general counsel, BAYER Three years ago, under Harnier’s leadership, the legal team at Bayer, the German pharmaceuticals and life sciences company, moved its contracting, data privacy...
...Investors are betting that Eisai, a $20bn pharmaceutical company still little known outside of Japan, can succeed where many larger companies have failed....
...If people are finishing Paxlovid after five days and following CDC guidance and going back into the world, yet 12 days later they are highly infectious, we have to know,” he said....
...Accordingly, big pharma groups like Pfizer, Bayer and Regeneron have taken note, forming partnerships with the pioneers....
...“Now within that five days, you think about the pathway to care....
...Some healthcare experts believe the vaccine could win over vaccine sceptics who have so far resisted getting jabs....
...Johnson & Johnson, one of the world’s largest healthcare companies, is facing thousands of lawsuits from people alleging they got cancer from using one of their oldest products: talc-based baby powder....
...Peter Lebowitz, head of J&J’s global oncology division, told the Financial Times that “before 2015, in the early days”, Chinese biotech companies were focused on formulating “slightly better versions of...
International Edition